|
注册号: Registration number: |
ChiCTR2200066625 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-27 10:24:51 |
|
注册时间: Date of Registration: |
2022-12-12 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
探究不同运动类型对轻度认知障碍患者认知脑功能的影响机制 |
|
Public title: |
To explore the influence mechanism of different types of exercise on cognitive brain function in patients with Mild Cognitive Impairment |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
探究不同运动类型对轻度认知障碍患者认知脑功能的影响机制 |
|
Scientific title: |
To explore the influence mechanism of different types of exercise on cognitive brain function in patients with Mild Cognitive Impairment |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张燕妮 |
研究负责人: |
林强 |
|
Applicant: |
Zhang Yanni |
Study leader: |
Lin Qiang |
|
申请注册联系人电话: Applicant telephone: |
+86 13544482014 |
研究负责人电话:
Study leader's |
+86 18922497674 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yannizhang0828@gzhmu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
qianglin0925@gzhmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省广州市黄埔区港湾路621号 |
研究负责人通讯地址: |
广东省广州市黄埔区港湾路621号 |
|
Applicant address: |
621 Gangwan Road, Huangpu District, Guangzhou, Guangdong |
Study leader's address: |
621 Gangwan Road, Huangpu District, Guangzhou, Guangdong |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广州医科大学附属第五医院 |
||
|
Applicant's institution: |
The Fifth Affiliated Hospital of Guangzhou Medical University |
||
|
研究负责人所在单位: |
广州医科大学附属第五医院 |
||
|
Affiliation of the Leader: |
The Fifth Affiliated Hospital of Guangzhou Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
GYWY-L2022-90 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广州医科大学附属第五医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the Fifth Affiliated Hospital of Guangzhou Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-11-14 00:00:00 | ||
|
伦理委员会联系人: |
王小宝 |
||
|
Contact Name of the ethic committee: |
Wang Xiaobao |
||
|
伦理委员会联系地址: |
广东省广州市黄埔区港湾路621号 |
||
|
Contact Address of the ethic committee: |
621 Gangwan Road, Huangpu District, Guangzhou, Guangdong |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 20 85959127 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广州医科大学附属第五医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Fifth Affiliated Hospital of Guangzhou Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省广州市黄埔区港湾路621号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
621 Gangwan Road, Huangpu District, Guangzhou, Guangdong |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
广州医科大学2022-2023年度大学生科技创新项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Science and Technology Innovation Project of Guangzhou Medical University 2022-2023 |
||||||||||||||||||||||
|
研究疾病: |
轻度认知障碍 |
||||||||||||||||||||||
|
Target disease: |
Mild Cognitive Impairment |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
基于功能性近红外光谱技术(functional near-infrared spectroscopy, fNIRS)同步监测轻度认知障碍患者在不同类型运动中认知脑区血流动力学变化,探究轻度认知障碍患者在不同类型运动中认知脑功能的改善情况及其影响机制。 |
||||||||||||||||||||||
|
Objectives of Study: |
Functional near-infrared spectroscopy (fNIRS) was used to simultaneously monitor the hemodynamic changes of cognitive brain areas in patients with mild cognitive impairment during different types of exercise. To explore the improvement of cognitive brain function in patients with mild cognitive impairment (MCI) during different types of exercise and its influencing mechanism. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 有长期酗酒或长期服用利尿剂、镇定剂、抗抑郁药、抗癫痫药等会对认知功能产生影响的药物; 2. 被诊断患有神经系统退行性疾病,如阿兹海默症; 3. 存在严重的心血管疾病(如心脏或呼吸功能不全); 4. 存在伴有不平衡和步态障碍的肌肉骨骼疾病; 5. 使用助行工具(如拐杖); 6. 有严重的视觉/听觉/运动障碍; 7. 其他任何会对被试者充分并安全参加锻炼和/或认知训练产生障碍的因素; 8. 运动过程中血压升高超过预期或因其他原因导致发烧不退/持续性身体疼痛致合作终止; 9. 妊娠。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Have long-term alcohol abuse or long-term use of diuretics, sedatives, antidepressants, antiepileptic drugs and other drugs that will affect cognitive function; 2. Diagnosed with a neurodegenerative disease (e.g. Alzheimer's disease); 3. Presence of severe cardiovascular disease (such as cardiac or respiratory insufficiency); 4. Presence of musculoskeletal disorders with imbalance and gait disturbance; 5. Use walking AIDS (e.g., crutches); 6. Severe visual/hearing/movement disorders; 7. Any other factors that may hinder the full and safe participation of the subjects in exercise and/or cognitive training; 8. Termination of cooperation due to increased blood pressure than expected during exercise or persistent fever or persistent body pain for other reasons; 9. Pregnancy. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-11-15 00:00:00至 To 2023-02-28 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-12-15 00:00:00 至 To 2023-01-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
符合入选/排除标准的20名MCI受试者采用电脑随机数字表法随机(1:1)分为2组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Twenty MCI subjects who met the inclusion/exclusion criteria were randomly divided into two groups (1:1) by computer random number table method. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理将由研究团队专人负责,受试者参加研究及在研究中的个人资料均保密。所有的研究成员和研究相关方都会按要求对受试者的身份保密。这项研究结果发表时,将不会披露受试者个人的任何资料。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and management will be handled by special personnel of the research team, and the personal data of subjects in the study will be kept confidential. The identity of the subjects will be kept confidential by all study members and stakeholders as required. No personal information about the subjects will be disclosed when the study results are published. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |